FDA Guidance for Industry: Best Practices for Communication Between IND Sponsors and FDA During Drug Development
Title:
FDA Guidance for Industry: Best Practices for Communication Between IND Sponsors and FDA During Drug Development
Origin/Publisher:
FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM475586.pdf
Content:
The purpose of this guidance is to describe best practices and procedures for timely, transparent, and effective communications between investigational new drug application (IND) sponsors and FDA at critical junctures in drug development, which may facilitate earlier availability of safe and effective drugs to the American public.